As anticipated, P21 treatment significantly increased the abundance of PTEN protein in both cancer cell lines and effectively suppressed phosphorylated-AKT (p-AKT) and phosphorylated-mTOR (p-mTOR) levels, which are downstream signals of PTEN (Figure 1E). Here, AKT1 is linked to cancer.